1. Home
  2. SNCR vs NRXP Comparison

SNCR vs NRXP Comparison

Compare SNCR & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Synchronoss Technologies Inc.

SNCR

Synchronoss Technologies Inc.

HOLD

Current Price

$8.77

Market Cap

59.5M

Sector

Technology

ML Signal

HOLD

Logo NRX Pharmaceuticals Inc.

NRXP

NRX Pharmaceuticals Inc.

HOLD

Current Price

$2.32

Market Cap

70.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNCR
NRXP
Founded
2000
2015
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
59.5M
70.8M
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
SNCR
NRXP
Price
$8.77
$2.32
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$30.67
AVG Volume (30 Days)
142.8K
1.7M
Earning Date
03-10-2026
11-17-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$170,909,000.00
$242,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.37
$847.91
P/E Ratio
N/A
N/A
Revenue Growth
0.07
N/A
52 Week Low
$3.98
$1.58
52 Week High
$12.85
$4.02

Technical Indicators

Market Signals
Indicator
SNCR
NRXP
Relative Strength Index (RSI) 76.98 50.59
Support Level $8.60 $2.13
Resistance Level $8.73 $2.38
Average True Range (ATR) 0.11 0.16
MACD -0.09 -0.00
Stochastic Oscillator 94.12 43.79

Price Performance

Historical Comparison
SNCR
NRXP

About SNCR Synchronoss Technologies Inc.

Synchronoss Technologies Inc is a provider of white-label cloud, messaging, digital and network management solutions that enable its customers to keep subscribers, systems, networks and content in sync. The Synchronoss Personal CloudTM solution is designed to create an engaging and trusted customer experience through ongoing content management and engagement. The Synchronoss Personal CloudTM platform is a secure and scalable, white-label platform that allows its customers' subscribers to backup and protect, engage with, and manage their personal content. The company derives revenue from subscriptions and transaction-based fees. A majority of the firm's revenue is generated in the United States, and the rest is from countries across the world.

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

Share on Social Networks: